Prostate Cancer Information Center
Prostate cancer is the most commonly diagnosed cancer (other than skin cancer) among men in the United States. Each year, approximately 186,000 men will be diagnosed with prostate cancer. In order to reduce these numbers, researchers continue to explore new approaches to prostate cancer prevention. Work is also underway to refine tests used for the early detection of prostate cancer.
Advances in surgery, radiation therapy, and hormonal therapy have all contributed to improved prostate cancer survival. Currently, there are more than 2 million prostate cancer survivors living in the United States.
Understanding prostate cancer treatment options, the role of different doctors specializing in the treatment of prostate cancer, and how and when to access new and innovative prostate cancer treatment options available through clinical trials is essential in order to achieve the best outcome from prostate cancer treatment.
The Cancer Consultants Prostate Cancer Information Center has been designed to help patients understand options for prostate cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of prostate cancer.
Headline Prostate Cancer News 
Minimally Invasive Prostate Surgery May Have Pros and Cons
Laparoscopic prostatectomy may increase risk of incontinence and ED.
Addition of Androgen Deprivation Therapy Improves Survival
Update from Phase III trial in locally advanced prostate cancer
Prostate Cancer Hormone Therapy and Heart Disease
Certain types of hormone therapy may increase risk of heart disease.
Prostate Cancer Tips
What to Tell Children when Facing a Diagnosis of Cancer If you have children in your life, you already know that they tend to be creatures...
Chemotherapy for Older Patients with Cancer: What You Should Know About the Risk of a Low White Blood Cell Count As you may already know, chemotherapy works by attacking the rapidly dividing cells...
Cancer Vaccines: Stimulating the Immune System to Attack Cancer As the age of personalized medicine approaches, the look and feel of cancer treatment...
Prostate Cancer Management
Inspiration, Hope & Resources
Judith Giuliani: A Caregiver’s Perspective Rudy Giuliani’s wife discusses her partnership with her husband during his prostate...
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Prostate Cancer Clinical Trials
HRRC03-376 – Investigation of Protein Biomarkers of Prostate Cancer
90203 – A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
AT-101-CS-205 – A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination with Docetaxel and Prednisone versus Docetaxel and Prednisone in Men with chemotherapy-Naïve Metastatic HRPC.
 |
 |
 |
 |
